TNF-α levels increase shortly after initiation of TB treatment [31], causing tissue destruction, which could favor bacterial survival, and thus inhibition of TNF-α or other such pro-inflammatory pathways may be useful during the early phase of TB treatment. The gene discussed is TNF; the disease is tuberculosis.